4.5 x 5.0mm SHORT® Implant receives FDA clearance and CE mark.

Introduction of the Universal Abutment System.

Bicon introduces its keyless Guided Surgery System.

3.0 x 6.0mm NARROW® and SHORT® Implant receives FDA clearance and CE mark.

Introduction of TRINIA™, the metal-free dental CAD/CAM solution.

Fabrication of fully retrievable and screwless IAC® restorations utilizing CAD/CAM technology and metal- free materials.

5.0mm SHORT® Implants, 3.0 x 8.0mm NARROW® Implants and the MAX 2.5TM Implant System receive CE mark.

10-year anniversary of the Integrated Abutment Crown™ (IAC®).

3.0 x 8.0mm NARROW® Implant receives FDA clearance.

Bicon’s 25th Anniversary.

MAX 2.5™ Implant System, 4.0 x 5.0mm, and 4.0 x 6.0mm SHORT®Implant receive FDA clearance.

6.0 x 5.0mm SHORT® Implant is introduced and receives FDA clearance.

5.0 x 5.0mm SHORT® Implant is introduced and receives FDA clearance.

Completion of Bicon's state-of-the-art clinical and teaching facility.

4.5 x 6.0mm SHORT® Implant is introduced and receives FDA clearance.

Bicon celebrates the 20-year anniversary of its implant design.

Bicon introduces the Brevis™ Overdenture System.

A new formulation of SynthoGraft™ pure phase Beta-Tricalcium Phosphate is introduced.

5.0 x 6.0mm SHORT® Implant is introduced and receives FDA clearance.

FIRST Integrated Abutment Crown™ (IAC) as well as the promotion of extra oral cementation of crowns.

6.0 x 8.0mm implant is introduced and receives FDA clearance.

Clinical studies begin for the shortest implant available on the market today: Bicon’s 5.7mm SHORT® Implant.

Bicon’s implant system is introduced, including highly successful 8.0mm length implants which were considered very short at the time.

FIRST Grit-blasted, acid-treated, passivated implants in sterile packaging, known today as Bicon’s Integra-Ti™.

FIRST Titanium instrumentation.

FIRST Unique, 50RPM low-speed drills for socket preparation which harvest bone and do not require irrigation.

FIRST Unique sloping shoulder concept designed to help maintain crestal bone height and interdental papillae.

Driskell introduces the Titanodont implant, made of titanium alloy (Ti6Al4V-ELI) incorporating the same design features as the Synthodont.

FIRST Mechanically textured and acid etched bone/implant surfaces.

FIRST Complete interchangeability of abutment diameters, providing sensible biological width and offering the concept now being described as platform switching.

FIRST Locking taper implant to abutment connection providing 360˚ of universal abutment positioning and a bacterial seal.

Driskell introduces the Synthodont implant. It is the first truly successful, free-standing osseointegrated single tooth dental implant, specifically designed and sold for use in humans on a large scale, which has a one piece, non-submergible design.

Studies reveal highly effective load transmission from the plateau design implant to the surrounding bone by means of an osseointegrated multi-finned design. This design was shown to be inherently more effective for the distribution of occlusal forces to the bone than screws or any other mechanical load transmitting design used by other implant manufacturers.

Driskell demonstrates histologically a direct bone to implant interface using free-standing tooth implants in Rhesus Monkeys. This phenomenon is now known as osseointegration.

Initial research begins on Beta-Tricalcium Phosphate, a synthetic bone graft material.

Thomas Driskell initiates his dental implant research.

US Army Medical Research and Development Command Dental Research Division funds the development of a free standing single tooth replacement implant that could be placed into a fresh extraction site, and the development of synthetic bone grafting materials for the repair of avulsive wounds.